Northwestern Mutual Wealth Management CO Avidity Biosciences, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $121 Billion
- Q1 2025
A detailed history of Northwestern Mutual Wealth Management CO transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 115 shares of RNA stock, worth $3,712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
115
Previous 14
721.43%
Holding current value
$3,712
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding RNA
# of Institutions
253Shares Held
110MCall Options Held
517KPut Options Held
717K-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$366 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$313 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$298 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$278 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.93MShares$256 Million3.76% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.68B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...